Kuros Biosciences AG a biopharmaceutical company that engages in the development and commercialization for tissue repair and bone regeneration products.
Business Segments
The company operates through Medical Devices, Pharmaceuticals, and Legacy Por…
Analysis
Quality compounder
Kuros Biosciences AG is a quality compounder: a well-run business trading at a price that reflects what it is worth. One caution: reported profits have recently run ahead of actual cash, which we track closely.
The price is expensive. You pay 368.5× its owner earnings: the cash an owner could take out each year, which is in the historically expensive zone.
The trajectory is moderate and the balance sheet is sturdy. The company scores 14/20 on our value-creation score: strong value creator.
What to watch: Some accounting patterns deserve a closer look. Reported profits have run ahead of actual cash for several periods. As always: this describes the company's numbers; it is not a recommendation.
360° rank · history
1007550250
Mar 202680
27
2026
All-time high
80
Mar 2026
All-time low
27
Jun 2026
Average rank
54
across all years
Detailed & Historical Ranks
Deep dive into 15 detailed ranks and 3 years of history.
Current202520242023
Price/Sales
46
—
—
—
Price/Earnings
1
—
—
—
Price/Book
7
—
—
—
Dividend Yield
1
—
—
—
Value (overall)
1
—
—
—
Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.